Previous animal experiments have suggested that EA-induced neuromodulation in AD model mice included regulation of Aβ protein, tau phosphorylation, neuroinflammation, brain plasticity, neuron apoptosis, mitochondrial activity, and blood–brain barrier function. This evidence concerns the gene MAPT and Alzheimer disease.